These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15329138)

  • 1. A brachytherapy template approach to standardize saturation prostatic biopsy.
    Petrou SP; Igel TC
    BJU Int; 2004 Sep; 94(4):677. PubMed ID: 15329138
    [No Abstract]   [Full Text] [Related]  

  • 2. A brachytherapy template approach to standardize saturation prostatic biopsy.
    Kommu S; Emtage JB; Watkin N
    BJU Int; 2004 Sep; 94(4):676-7. PubMed ID: 15329137
    [No Abstract]   [Full Text] [Related]  

  • 3. A brachytherapy template approach to standardize saturation prostatic biopsy.
    Bott SR; Henderson A; McLarty E; Langley SE
    BJU Int; 2004 Mar; 93(4):629-30. PubMed ID: 15008745
    [No Abstract]   [Full Text] [Related]  

  • 4. MRI-guided diagnosis and treatment of prostate cancer.
    D'Amico AV; Cormack RA; Tempany CM
    N Engl J Med; 2001 Mar; 344(10):776-7. PubMed ID: 11236795
    [No Abstract]   [Full Text] [Related]  

  • 5. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
    Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy.
    Sengupta S; Davis BJ; Mynderse LA; Sebo TJ; Cheville JC; Lohse CM; Hillman DW; Haddock MG; Wilson TM
    Urology; 2006 Oct; 68(4):810-4. PubMed ID: 17070358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer.
    Weight CJ; Ciezki JP; Reddy CA; Zhou M; Klein EA
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):347-50. PubMed ID: 16545922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on prostate brachytherapy for localized prostate cancer.
    Crook J
    J Urol; 2008 May; 179(5 Suppl):S25-6. PubMed ID: 18405744
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturation biopsy for detecting and characterizing prostate cancer.
    Jones JS
    BJU Int; 2007 Jun; 99(6):1340-4. PubMed ID: 17428241
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histological assessment of the effectiveness of radiation therapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1987; 33(4):3-9. PubMed ID: 3296433
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
    Nurani R; Wallner K; Merrick G; Virgin J; Orio P; True LD
    J Urol; 2007 Nov; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy for prostate cancer: is the pretreatment prostate volume important?
    Meyer JP; Bell CR; Elwell C; Kunkler RB
    BJU Int; 2008 Dec; 102(11):1585-8. PubMed ID: 18990138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive transperineal template biopsies of prostate: modified technique and results.
    Bott SR; Henderson A; Halls JE; Montgomery BS; Laing R; Langley SE
    Urology; 2006 Nov; 68(5):1037-41. PubMed ID: 17095067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.
    Simon J; Kuefer R; Bartsch G; Volkmer BG; Hautmann RE; Gottfried HW
    BJU Int; 2008 Aug; 102(4):459-62. PubMed ID: 18325061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
    W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
    Guzzo TJ; Levin BM; Lee R; Guo M; Chen Z; Whittington R; Tomaszewski J; Malkowicz SB
    Urology; 2008 Apr; 71(4):723-7. PubMed ID: 18387401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.